EST NLS Pharmaceutics (NLSP) files $75M mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power of ...

Researchers from the Monash Milk Team have published a new study demonstrating the power of human milk as a highly effective ...

NLS Pharmaceutics Ltd. ("NLS") (Nasdaq: NLSP), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for rare and complex central nervous ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The University of Utah is in danger of losing an estimated $50 million in medical research grant dollars a year because of a ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

Alcami Corporation ("Alcami"), a leading contract development and manufacturing organization (CDMO), today announced the ...

NLS Pharmaceutics stock is trading higher on Friday after the company announced its merger with Kadimastem has been approved by Kadimastem shareholders.

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...